Tudor Investment Corp
CRVS icon

Tudor Investment Corp’s Corvus Pharmaceuticals CRVS Stock Holding History

Tudor Investment Corp’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$402K Buy
+27,494
New +$439K ﹤0.01% 2968
2016
Q2 		– Sell
-10,000
Closed -$145K – 1672
2016
Q1 		$145K Buy
+10,000
New +$143K ﹤0.01% 1567

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tudor Investment Corp's CRVS Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Corvus Pharmaceuticals (CRVS) in Q1 2026: 27,494 shares worth $402K. The stake represents ﹤0.01% of the portfolio and ranks #2968 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in CRVS as recently as Q1 2016.

Tudor Investment Corp first reported a position in CRVS in Q1 2016 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold CRVS as of Q1 2026.

  • Tudor Investment Corp held 27,494 shares of Corvus Pharmaceuticals worth $402K as of Q1 2026.
  • Corvus Pharmaceuticals was a new Tudor Investment Corp position in Q1 2026.
  • Corvus Pharmaceuticals made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2968 holding.
  • Tudor Investment Corp first reported a position in Corvus Pharmaceuticals in Q1 2016 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.